Vijaya Diagnostic Centre Ltd Share Price – NSE /  BSE

Healthcare, Small Cap

According to a regulatory filing, Prasad's resignation will take effect from August 8, 2026, which will be his last working day with the company.

The diagnostic services provider said it places on record its appreciation for the services rendered by Prasad and acknowledged his contributions during his tenure with the company.

No further details regarding his successor were disclosed in the filing.

Vijaya Diagnostic Centre is one of India?s largest integrated diagnostic chains. The company offers comprehensive diagnostic services ranging from basic pathology to high-end radiology.

The company?s consolidated net profit jumped 37.64% to Rs 47.92 crore on 26.62% rise in revenue from operations to Rs 219.37 crore in Q4 FY26 over Q4 FY25.

The scrip shed 0.32% to Rs 1,295 on the BSE.

Powered by Capital Market - Live News

According to the company's regulatory filing, Shah will cease to hold the position on or before July 24, 2026.

The company did not disclose the reason for the resignation in the filing. Further details regarding the appointment of a new CFO are awaited.

The disclosure was made in compliance with regulatory requirements under stock exchange listing norms.

Vijaya Diagnostic Centre is one of India?s largest integrated diagnostic chains. The company offers comprehensive diagnostic services ranging from basic pathology to high-end radiology.

The company?s consolidated net profit jumped 37.64% to Rs 47.92 crore on 26.62% rise in revenue from operations to Rs 219.37 crore in Q4 FY26 over Q4 FY25.

The scrip shed 0.09% to Rs 1305.90 on the BSE.

Powered by Capital Market - Live News

Vijaya Diagnostic Centre announced that the Board of Directors of the Company at its meeting held on 7 May 2026, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 200%) , subject to the approval of the shareholders.

Net profit of Vijaya Diagnostic Centre rose 37.49% to Rs 47.93 crore in the quarter ended March 2026 as against Rs 34.86 crore during the previous quarter ended March 2025. Sales rose 26.63% to Rs 219.38 crore in the quarter ended March 2026 as against Rs 173.24 crore during the previous quarter ended March 2025.

For the full year,net profit rose 20.30% to Rs 172.98 crore in the year ended March 2026 as against Rs 143.79 crore during the previous year ended March 2025. Sales rose 19.49% to Rs 814.20 crore in the year ended March 2026 as against Rs 681.39 crore during the previous year ended March 2025.

Powered by Capital Market - Live News